.

Deeper Knowledge, Faster

  • Predict branded drug patent expiration
  • Uncover prior art in expired and abandoned patents
  • Set up watchlists for daily email updates

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

UBS
Merck
Accenture
Medtronic
AstraZeneca
Boehringer Ingelheim
Healthtrust
US Department of Justice
McKesson
Chubb

Generated: June 24, 2017

DrugPatentWatch Database Preview

LEVOXYL Drug Profile

« Back to Dashboard

Which patents cover Levoxyl, and when can generic versions of Levoxyl launch?

Levoxyl is a drug marketed by King Pharms and is included in one NDA. There are three patents protecting this drug.

This drug has twenty-six patent family members in nine countries.

The generic ingredient in LEVOXYL is levothyroxine sodium. There are ten drug master file entries for this compound. Forty-two suppliers are listed for this compound. Additional details are available on the levothyroxine sodium profile page.

Summary for Tradename: LEVOXYL

Patents:3
Applicants:1
NDAs:1
Suppliers / Packagers: see list3
Bulk Api Vendors: see list57
Clinical Trials: see list1
Patent Applications: see list6,534
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:LEVOXYL at DailyMed

Pharmacology for Tradename: LEVOXYL

Ingredient-typeThyroxine
Drug Classl-Thyroxine
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
King Pharms
LEVOXYL
levothyroxine sodium
TABLET;ORAL021301-011May 25, 2001AB1,AB3RXYesYes7,067,148► SubscribeY ► Subscribe
King Pharms
LEVOXYL
levothyroxine sodium
TABLET;ORAL021301-010May 25, 2001AB1,AB3RXYesNo7,067,148► SubscribeY ► Subscribe
King Pharms
LEVOXYL
levothyroxine sodium
TABLET;ORAL021301-011May 25, 2001AB1,AB3RXYesYes7,101,569► Subscribe ► Subscribe
King Pharms
LEVOXYL
levothyroxine sodium
TABLET;ORAL021301-010May 25, 2001AB1,AB3RXYesNo6,555,581► Subscribe ► Subscribe
King Pharms
LEVOXYL
levothyroxine sodium
TABLET;ORAL021301-001May 25, 2001AB1,AB3RXYesNo7,067,148► SubscribeY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Tradename: LEVOXYL

Country Document Number Estimated Expiration
Brazil0207297► Subscribe
Canada2440190► Subscribe
MexicoPA03007338► Subscribe
South Korea20040100835► Subscribe
European Patent Office1474103► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Julphar
US Department of Justice
Merck
Argus Health
Colorcon
Medtronic
Chinese Patent Office
Healthtrust
Johnson and Johnson
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot